glp 1 hfpef GLP-1 receptor agonists, including semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in GLP-1 Receptor Agonists Among Patients
Description
Cost-effectiveness analysis of 4 GLP-1RAs in the treatment of obesity in a US setting

3.6 Industry funding disclosure Among the included randomized controlled trials (n = 93), 60 trials (64%) were fully or partially funded by pharmaceutical sponsors (e.g., Novo Nordisk, Eli Lilly)

Lipase is the primary marker to monitor

Choose the best plan for you
Wear it up to 8 hours

Grease a pie plate or 8x8 glass dish
